- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.11. | Innovent gets OK for China's first home-grown IL-23p19 drug | ||
| 28.11. | Digital platform for GPs 'could transform clinical trials' | ||
| 28.11. | Wellcome donates £2m to UK's digital mental health drive | ||
| 28.11. | Tonix launches its new fibromyalgia drug in US | ||
| 27.11. | Wearable alert system for epileptics set for European launch | ||
| 27.11. | Vaderis drug lends hope to patients with bleeding disease HHT | ||
| 27.11. | Platform tests commercial algorithms for NHS use for bias | ||
| 27.11. | FDA starts priority review of BeOne's Venclexta rival | ||
| 27.11. | Lundbeck bows out of bidding war for Avadel | ||
| 26.11. | Novo Nordisk spends priority voucher on Wegovy filing | ||
| 26.11. | Sanofi's Paris HQ raided in tax fraud probe | ||
| 26.11. | Kelonia's in vivo CAR-T data will feature at ASH | ||
| 26.11. | Otsuka joins IgAN market with Voyxact approval in US | ||
| 26.11. | Latest Medicare pricing cuts promise $12bn in savings | ||
| 25.11. | Data sets up phase 3 trials for Novo's amycretin in diabetes | ||
| 25.11. | NICE backs NHS use of Autolus' leukaemia CAR-T | ||
| 25.11. | £800m life sciences cluster opens in London | ||
| 25.11. | Innovent files high-dose mazdutide for obesity in China | ||
| 25.11. | Novartis' SMA gene therapy cleared for wider use in US | ||
| 24.11. | Angelini rapped for criticism of EMA approval | ||
| 24.11. | Disappointment as Novo's oral GLP-1 fails in Alzheimer's | ||
| 24.11. | Stroke data breathes life back into Bayer's asundexian | ||
| 24.11. | J&J abandons Alzheimer's antibody in setback for tau | ||
| 24.11. | Lilly becomes first $1trn+ pharma company | ||
| 21.11. | Waltz dances into direct-to-employer sales of obesity drugs |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .